Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study

Christian Kjellander, Magnus Björkholm, Owe Källman, Christian G. Giske, Caroline E. Weibull, Thorvardur J. Löve, Ola Landgren, Sigurdur Y. Kristinsson

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Infectious complications in chronic lymphocytic leukemia (CLL) represent a major cause of morbidity and mortality. The aim of the study was to investigate temporal trends in bloodstream infections (BSIs) among patients with CLL. Individuals with blood cultures were linked to Swedish Cancer Registry and divided into three time periods (1988–1993, 1994–1999, and 2000–2006) according to year of CLL diagnosis. CLL patients (n = 275) with 1092 blood culture episodes were identified and linked to the nationwide Cause of Death Registry and Swedish Patient Registry (to retrieve information on splenectomies). The most common causes of BSI among CLL patients were Escherichia coli (11/43, 15/78, and 9/33), Streptococcus pneumoniae (7/43, 13/78, and 6/33), Pseudomonas aeruginosa (2/43, 8/78, and 3/33), Staphylococcus aureus (1/43, 6/78, and 6/33), and Viridans streptococci (5/43, 6/78, and 2/33). Coagulase-negative staphylococci was the most frequent microorganism found in blood cultures (22/70, 23/106, and 5/41, respectively) but is a frequent contaminant. Based on the largest study to date on BSI in CLL patients, we found a stable proportion of Gram-positive to Gram-negative bacteria and no temporal change of distribution was observed for BSIs 1988–2006.

Original languageEnglish (US)
Pages (from-to)871-879
Number of pages9
JournalAnnals of Hematology
Volume95
Issue number6
DOIs
StatePublished - May 1 2016
Externally publishedYes

Keywords

  • Bloodstream infections
  • Chronic lymphocytic leukemia
  • Infections
  • Prognosis
  • Splenectomy

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study'. Together they form a unique fingerprint.

Cite this